News|Articles|June 2, 2001
- Pharmaceutical Technology-06-02-2001
- Volume 25
- Issue 6
Viral Clearance Strategies for Biopharmaceutical Safety
Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.
Advertisement
Articles in this issue
about 25 years ago
Outsourcing Outlookabout 25 years ago
Managing Risks and Resourcesabout 25 years ago
Blister News: COC Resin, Foil, and Lidding Innovationsabout 25 years ago
Managing the Risks in Outsourcingabout 25 years ago
Systemic Drug Delivery via the Buccal Mucosal RouteAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
4
The Implications of the FDA’s New Finalized Guidance Documents
5